Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004631118 | SCV005122322 | uncertain significance | Inborn genetic diseases | 2024-03-26 | criteria provided, single submitter | clinical testing | The c.968T>G (p.V323G) alteration is located in exon 1 (coding exon 1) of the IRF2BPL gene. This alteration results from a T to G substitution at nucleotide position 968, causing the valine (V) at amino acid position 323 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |